These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 2410766)

  • 1. [DNA measurements by DAPI staining in breast cancer--correlation between DNA content and nuclear grade].
    Nishi T; Okajima K; Mizutani H
    Nihon Geka Gakkai Zasshi; 1985 May; 86(5):645. PubMed ID: 2410766
    [No Abstract]   [Full Text] [Related]  

  • 2. [DAPI-DNA cytofluorometric study of glioma cells--application of DAPI-DNA cytofluorometry to paraffin embedded archival glioma tissue for nuclear DNA content analysis].
    Nagashima R
    No To Shinkei; 1990 Apr; 42(4):352-9. PubMed ID: 1697181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological characteristics of breast cancers with various DNA content].
    Loboda VI
    Vopr Onkol; 1980; 26(12):23-8. PubMed ID: 7467215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [UV-microspectrophotometric and flow cytometric analysis of the same samples using DAPI/HP staining].
    Tanaka N; Ohtsuka S; Matsuyama M; Teramoto M; Ueno K; Inoue M; Honda S; Morita J; Morita M; Omata K
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):731-6. PubMed ID: 7683863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laser flow cytofluorometry as a supplementary method of determining the degree of tumor differentiation in breast cancer patients].
    Bogatyrev VN; Ermilova VD; Petrova AS
    Arkh Patol; 1986; 48(1):44-8. PubMed ID: 2421692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [DNA analysis by flow cytometry in breast carcinoma].
    Tsuchiya A; Sekikawa K; Sato H; Ando Y; Suzuki S; Nihei M; Rokkaku Y; Nomizu T; Kimijima I; Abe R
    Gan No Rinsho; 1989 Jan; 35(1):30-4. PubMed ID: 2921806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multiparametric cytometric analysis of hepatocellular carcinoma and its allied lesions combining DNA ploidy analysis with morphometry using DAPI/HP double staining].
    Tanaka N; Ohtsuka S; Honda S; Matsuyama M; Teramoto M; Ueno K; Inoue M; Morita J; Morita M; Omata K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():197-204. PubMed ID: 7541978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
    Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
    Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear DNA content in breast carcinomas with neuroendocrine differentiation.
    Nesland JM; Pettersen EO; Fosså SD; Høie J; Johannessen JV
    J Pathol; 1986 Nov; 150(3):181-5. PubMed ID: 3027292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric nuclear DNA content of fresh and paraffin-embedded tissues of breast carcinomas and fibroadenomas.
    De Vita R; Calugi A; Eleuteri P; Maggi O; Nassuato C; Vecchione A
    Eur J Basic Appl Histochem; 1991; 35(3):233-44. PubMed ID: 1718443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytophotometric measurements of nuclear DNA content values in human breast lesions.
    Enchev VG; Dobreva PV
    Arch Geschwulstforsch; 1987; 57(1):31-7. PubMed ID: 3566463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular DNA contact and its correlation with histopathological prognostic parameters in carcinoma of the breast.
    Chaturvedi S; Singh S; Khanna HD; Khanna S; Khanna R
    Indian J Pathol Microbiol; 1998 Jul; 41(3):337-42. PubMed ID: 9805857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear DNA content and nuclear atypia. Relation to survival in patients with breast adenocarcinoma and serious ovarian tumors.
    Erhardt K; Silfverswärd C; Auer G
    Anticancer Res; 1989; 9(5):1325-30. PubMed ID: 2589823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleic acid (DNA) content of primary carcinoma and response to endocrine or cytotoxic drug therapies in patients with advanced breast cancer.
    Mitchell I; Deshpande N; Millis R; Rubens RD
    Eur J Surg Oncol; 1985 Sep; 11(3):251-6. PubMed ID: 4029405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear grading and flow cytometric DNA pattern in fine-needle aspirates of primary breast cancer.
    Bozzetti C; Nizzoli R; Naldi N; Guazzi A; Camisa R; Manotti L; Pilato FP; Mazzini G; Cocconi G
    Diagn Cytopathol; 1996 Aug; 15(2):116-20. PubMed ID: 8872432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationships between image cytometric DNA index, proliferation fraction and multiploidy and conventional nuclear grade in breast carcinoma.
    Smith FB; Zappi ME
    Mod Pathol; 1993 Sep; 6(5):606-11. PubMed ID: 7504261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of nuclear image analysis to diagnosis in oncology].
    de Launoit Y; Kiss R; Pasteels JL
    Bull Mem Acad R Med Belg; 1989; 144(10):459-66; discussion 467-8. PubMed ID: 2483532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Megakaryocyte ploidy in patients with myelodysplastic syndrome--by microcytofluorometry with DAPI staining after removal of Wright-Giemsa staining].
    Kobayashi Y; Ozawa M; Maruo N; Kondo M
    Rinsho Ketsueki; 1989 Nov; 30(11):1915-22. PubMed ID: 2481752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochemical classification of nonpalpable breast carcinoma.
    Fallenius A; Svane G; Auer G; Caspersson TO
    Anal Quant Cytol; 1983 Mar; 5(1):9-12. PubMed ID: 6303171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Feulgen hydrolysis profiles of [corrected] a metastatic lung tumour in lymph node and a primary breast carcinoma.
    Mays RG
    Med Lab Sci; 1987 Oct; 44(4):307-11. PubMed ID: 2460713
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.